AlloVir

0 followers

‌

AlloVir, formerly ViraCyte, was founded in 2013 and is the leader in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.

Industries

Headquarters

Houston, United States

Employees

Links

Org chart

Chief Scientific Officer

Ann Leen

Collapse

Vp, Biometrics

Executive Director, R&d Counsel

Francesca Cardarelli

Senior Medical Director Clinical Development

Jennifer Leung Imura

Director, Clinical, Medical And Regulatory Affairs IT Business Partner

Julie Mabalot Luk

Director, Clinical Operations And Early Portfolio Management

President and Chief Financial Officer

Teams

Regulatory Affairs Team

14 members

Leadership Team

2 members

Clinical Operations Team

3 members

Similar companies

SpringWorks Therapeutics

5 followers

Halozyme Therapeutics

4 followers

Prime Medicine

3 followers

Generation Bio

2 followers

Celldex Therapeutics

2 followers

Rigel Pharmaceuticals

2 followers

Viridian Therapeutics

2 followers

Modern Meadow

2 followers

Vividion Therapeutics

1 follower

Mersana Therapeutics

1 follower

ReCode Therapeutics

1 follower

Explore companies